Lichtenberger, Lenard M. http://orcid.org/0000-0003-2746-1627
Funding for this research was provided by:
Office of Extramural Research, National Institutes of Health (R21182798)
Article History
Received: 27 July 2023
Accepted: 15 September 2023
First Online: 8 December 2023
Declarations
:
: Dr. Lichtenberger is a co-founder of and shareholder in PLx Pharma Inc. that is developing a phosphatidylcholine (PC)-associated aspirin and related PC-NSAIDs for cardiovascular and other potential NSAID therapeutic indication.